NYSE:RMDMedical Equipment
ResMed And Oura Link Consumer Sleep Data To Clinical Care Pathways
ResMed (NYSE:RMD) and Oura announced a partnership to connect consumer sleep insights with clinical sleep care pathways.
The collaboration focuses on sleep health education and directing Oura users who may have sleep issues toward ResMed-supported resources.
The move is intended to broaden access to sleep care while expanding both companies' presence in digital health.
For investors watching NYSE:RMD, this partnership comes at a time when the stock is trading around $190.57 and has faced...